Devia Exits Stealth With AI Agents for Pharma Quality Probes
Zurich spin-out Devia says pilot users halved deviation investigation time with AI agents that draft root causes and CAPAs while humans keep approval authority.
Topic
Capa
Topic
Topic
Topic
Zurich spin-out Devia says pilot users halved deviation investigation time with AI agents that draft root causes and CAPAs while humans keep approval authority.